Customer Appreciation Sale.
15% off with promo code "APPRECIATION2023" on check out or purchase order
Biological Activity
Luseogliflozin is an orally active second-generation sodium-glucose co-transporter 2 (SGLT2) inhibitor developed by Taisho Pharmaceutical for the treatment of patients with type 2 diabetes mellitus (T2DM).
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 23.01 mL | 115.06 mL | 230.12 mL |
0.5 mM | 4.6 mL | 23.01 mL | 46.02 mL |
1 mM | 2.3 mL | 11.51 mL | 23.01 mL |
5 mM | 0.46 mL | 2.3 mL | 4.6 mL |
*The above data is based on the productmolecular weight 434.55. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Catalog Num | A13476 |
---|---|
Actions | Inhibitor |
CAS No. | 898537-18-3 |
Formula | C23H30O6S |
M. Wt | 434.55 |
Purity | >98% |
Synonyms | TS 071, TS071, TS-71 |
SMILES | CCOC1=CC=C(C=C1)CC2=C(C=C(C(=C2)[C@H]3[C@@H]([C@H]([C@@H]([C@H](S3)CO)O)O)O)OC)C |
Storage | Store lyophilized at -20ºC, keep desiccated. |
Product Tags
Product Questions
Product Questions
No Questions
Keywords:buy Luseogliflozin | Luseogliflozin Supplier | purchase | cost | manufacturer | order | distributor | buy 898537-18-3| 898537-18-3 Supplier | purchase 898537-18-3 | 898537-18-3 cost | 898537-18-3 manufacturer | order 898537-18-3 | 898537-18-3 distributor